Glycemic Impact of Myo-inositol in Pregnancy

Status unconfirmed · Not applicable

Conditions studied: Gestational Diabetes Mellitus as Antepartum Condition

In brief

Myo-inositol has been shown to decrease the rate of diabetes in pregnancy in European studies. It is not known exactly how this occurs or what it does to the sugar when the supplement is taken. This study purpose is to look at the patient's sugar levels while taking the supplement to see if the overall levels of sugar go down. We hypothesize that in addition to sugar levels, other hormones influencing diabetes will be altered.

Key facts

Study ID

NCT02149992

Run by

Oregon Health and Science University

People needed

40

Starts

2014-11-01

Expected to finish

2016-08-01

Last updated by the study team

2016-05-18

Who can join

Age: 13 and older. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• English-speaking
• singleton
• pregnant females between 20-28 weeks of gestation at time of enrollment PLUS (either of the following)
• High risk including women must have passed routine glucose screening and have greater than or equal to 1 of the following high risk criteria: first degree family member with diabetes mellitus, previous pregnancy with gestational diabetes, PCOS, or body mass index great than or equal to 30.
• Gestational diabetes diagnosed in current pregnancy based on IADPSG or NIH consensus diagnostic recommendation

You may not qualify if…

• pre-pregnancy diagnosis of diabetes mellitus
• renal disease
• immunocompromised
• currently taking immunosuppressive medications
• age <13 years old
• non-English speaking
• multifetal gestation.

Where it is running

• Oregon Health and Science University — Portland, Oregon, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.